FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump
FBR Capital Markets initiated coverage on shares of TherapeuticsMD (NYSE: TXMD) with an “outperform” rating.
The target price for TherapeuticsMD is set to $34.
TherapeuticsMD shares have jumped 54.10% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.
TherapeuticsMD's shares jumped 32.93% to $5.49 in pre-market trading.
Latest Ratings for TXMD
|Apr 2016||Goldman Sachs||Initiates Coverage on||Buy|
|Jun 2015||Guggenheim Securities||Initiates Coverage on||Buy|
|Jul 2014||FBR Capital||Initiates Coverage on||Outperform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.